3I
Schedule 13D filing
3i, LP disclosed a 9.9% stake in Valion Bio, Inc. (VBIO)
3i, LP reported owning 9.9% of Valion Bio, Inc. (VBIO) (3,334,139 shares) in a Schedule 13D filed Aug 28, 2026.
A 13D means the holder may push for changes at the company.
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.